Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2025-07-30 Governance Information
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于取消监事会并修订《公司章程》及修订、制定公司部分制度的公告
Governance Information Classification · 95% confidence The document is a detailed announcement from a company about the cancellation of its supervisory board and the revision of its Articles of Association (公司章程) along with other company systems. It references compliance with the new Company Law of the People's Republic of China and related regulatory rules effective in 2024 and 2025. The content includes detailed comparisons of the Articles of Association before and after amendments, covering governance structure, shareholder rights, board responsibilities, and other corporate governance matters. There is no indication that this is a full annual or interim financial report, audit report, or earnings release. It is not a simple announcement of a report publication but a substantive governance-related document. The focus on company governance, board structure, and internal rules aligns with the definition of Governance Information (CGR). Therefore, the document should be classified as Governance Information (CGR).
2025-07-30 Chinese
益丰药房关于召开2025年第二次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about the convening of the 2025 second extraordinary general meeting of shareholders (临时股东会) for Yifeng Pharmacy Chain Co., Ltd. It details the meeting date, voting methods, agenda items to be discussed and voted on, and instructions for shareholders on how to participate and vote. It includes an authorization proxy form for shareholders to delegate voting rights. There are no financial statements or financial performance data included. The document is an announcement of a shareholders meeting and related procedural information, not a report or results announcement. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting procedures rather than solicitation materials or voting results, it is best classified as Proxy Solicitation & Information Statement (PSI). The document length is 3144 characters, which is consistent with a detailed meeting notice and proxy statement. Confidence is high due to clear meeting and voting procedural content and absence of financial data or results.
2025-07-30 Chinese
益丰药房第五届监事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 益丰大药房连锁股份有限公司 regarding several internal governance matters, including the proposal to cancel the Supervisory Board and amend the company bylaws, extension of investment project deadlines, and use of own funds for project payments. It includes voting results and references to other announcements on the stock exchange website. The document is short (1743 characters), contains no financial statements or detailed financial data, and primarily reports on board meeting decisions and resolutions. It is not a full annual or interim report, audit report, or earnings release. It is not a call transcript or investor presentation. It is not a report publication announcement since it contains substantive meeting resolution content. The document fits best under Board/Management Information (MANG) as it relates to board/supervisory decisions and governance changes.
2025-07-30 Chinese
关联交易管理制度（2025年7月修订）
Governance Information Classification · 95% confidence The document is titled '益丰大药房连锁股份有限公司 关联交易管理制度' which translates to 'Yifeng Pharmacy Chain Co., Ltd. Related Party Transaction Management System'. It is a detailed internal policy document outlining the management, disclosure, decision-making procedures, pricing, and risk prevention related to related party transactions. It references relevant laws and stock exchange rules, and includes detailed procedural and governance content. There is no indication that this is a financial report, earnings release, or announcement of voting results. It is not a report publication announcement or a regulatory filing in the sense of a compliance document. Instead, it is a governance-related document detailing internal rules and procedures for managing related party transactions, which falls under Governance Information (CGR). The document length is over 10,000 characters, indicating it is a full policy document rather than a brief announcement.
2025-07-30 Chinese
子公司管理制度（2025年7月修订）
Governance Information Classification · 95% confidence The document is titled '子公司管理制度' (Subsidiary Management System) and is a detailed internal governance and management policy document for subsidiaries of the company 益丰大药房连锁股份有限公司. It covers governance structure, personnel management, financial management, investment decision-making, information disclosure, internal audit supervision, and performance evaluation. The document is approved by the company's board of directors and is dated July 30, 2025. It is a formal internal governance document rather than a financial report, earnings release, or announcement. It does not contain financial statements or results, nor is it a regulatory filing or announcement of a report. It fits best under Governance Information (CGR), which includes reports detailing the company's internal rules, board structure, and governance practices.
2025-07-30 Chinese
中信证券股份有限公司关于益丰大药房连锁股份有限公司使用自有资金支付募投项目部分款项并以募集资金等额置换的核查意见
Regulatory Filings
2025-07-30 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.